Fudan Fuhua subsidiary fined 267 million or replacing business tax with value-added tax(VAT) after t aapt.exe

Fudan Fuhua subsidiary fined 267 million or replacing business tax with value-added tax(VAT) after the first big ticket hot column capital flows thousands of thousand shares stocks the latest Rating Rating diagnosis simulated trading client Sina App: Live on-line blogger to guide you with entries you earn will always let you find the reporter Zhu Ping Beijing reported reading Fuhua pharmaceutical invoices you, in the industry has been an open secret. With the "replacing business tax with value-added tax(VAT)", "two votes" in the implementation of some industries and even illegal illegal misdeeds gradually exposed. In September 13th, Shanghai Fudan Fuhua Polytron Technologies Inc (600624.SH) announced that its subsidiary of Shanghai Fudan Fuhua Pharmaceutical Co Ltd (hereinafter referred to as Fuhua pharmaceutical) in September 9, 2016 received national and local tax administrative penalties, fines totaling 267 million yuan. Fudan Fuhua related to the twenty-first Century Economic Herald reporter said that if the ticket trip, will have a certain impact on the performance of Fudan Fuhua, Fuhua pharmaceutical will make statements and defenses, applies for a hearing and appeals, and said the calculation method does not agree with part of state and local. Insiders pointed out that in July 2016, Fudan Fuhua is "replacing business tax with value-added tax(VAT)" after the implementation of the first home was pulling out of the pharmaceutical companies, and a large amount of fine, this year is also one of the largest pharmaceutical field. "More than other pharmaceutical industry, such as real estate, there are also false invoices, in the future," replacing business tax with value-added tax(VAT) "and" two votes ", or pharmaceutical enterprises face more challenges, such as need to change its marketing approach." Vice president of China Pharmaceutical Enterprise Management Association Niu Zhengqian pointed out. In the pharmaceutical business activities in the past, "votes" and "Guakao" behavior has been regarded as the medicine circulation industry’s ills. At present, under the two vote system, the pharmaceutical companies to deal with the financial and tax capacity is also full of challenges. Doctoral tutor Hu Yijian Shanghai University of Finance and Economics School of economics and management to the twenty-first Century economic report reporter pointed out that compliance is always the primary principle of enterprise management, for illegal phenomenon existed in the past, companies are now facing up or punishment, serious cases will likely hit the criminal law. Fudan Fuhua received 267 million tickets in September 13th, Fudan University announced that Shanghai received tax administrative penalty matters "tax notice": according to the "People’s Republic of China tax collection and management law", intends to Fuhua pharmaceutical should pay the value-added tax, city maintenance and construction tax at a fine of 1 times, a total of 147718733.39 yuan; at the same time, Shanghai also issued a tax the relevant notice, intends to Fuhua pharmaceutical should pay enterprise income tax at a fine of 1 times, a total of 118772115.13 yuan. The first inspection bureau of Shanghai Municipal State Taxation Bureau said, Fuhua pharmaceutical in July 2012 ~2014 November, accepting students in base of issuing false VAT invoices 1408 copies of goods for the Japanese production of glutathione in raw materials, quantity of 45500 kg, the amount of 814478633.04 yuan, tax 138461366.96 yuan. In addition, the company in the 2012~ theory相关的主题文章:

This entry was posted in Web Resources. Bookmark the permalink.

Comments are closed.